Showing items 161-170 of 1268 (127 Page(s) Totally)
<< < 12 13 14 15 16 17 18 19 20 21 > >>
View [10|25|50] records per page
| 國立成功大學 |
2022 |
Ledipasvir/Sofosbuvir for Patients Coinfected With Chronic Hepatitis C and Hepatitis B in Taiwan: Follow-up at 108 Weeks Posttreatment
|
Liu, C.J.;Sheen, I.S.;Chen, Chen C.Y.;Chuang, W.L.;Wang, H.Y.;Tseng, K.C.;Chang, T.T.;Yang, J.;Massetto, B.;Suri, V.;Camus, G.;Jiang, D.;Zhang, F.;Gaggar, A.;Hu, T.H.;Hsu, Y.C.;Lo, G.H.;Chu, Chu C.J.;Chen, J.J.;Peng, C.Y.;Chien, R.N.;Chen, P.J. |
| 國立成功大學 |
2022 |
The impact of body mass index on clinicopathological features of nonalcoholic fatty liver disease in Taiwan
|
Lin, C.-L.;Tai, C.-M.;Huang, J.-F.;Liu, C.-J.;Chen, H.-F.;Cheng, P.-N.;Chen, Chen C.-Y.;Peng, C.-Y.;Wang, C.-C.;Weng, S.-H.;Tseng, Tseng T.-C.;Kao, J.-H. |
| 臺大學術典藏 |
2021-12-01T06:03:21Z |
Efficacy and safety of cefepime treatment in Chinese patients with severe bacterial infections: In comparison with ceftazidime treatment
|
Chang S.-C.; Fang C.-T.; Hsueh P.-R.; Liu C.-J.; Sheng W.-H.; Hsieh S.-M.; Hung C.-C.; YEE-CHUN CHEN |
| 臺大學術典藏 |
2021-12-01T06:03:14Z |
Risk factors for ICU mortality in critically ill patients
|
YEE-CHUN CHEN; Lin S.-F.; Liu C.-J.; Jiang D.D.-S.; Yang P.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-12-01T02:30:43Z |
Efficacy and safety of cefepime treatment in Chinese patients with severe bacterial infections: In comparison with ceftazidime treatment
|
Chang S.-C.; Fang C.-T.; Hsueh P.-R.; Liu C.-J.; Sheng W.-H.; Hsieh S.-M.; CHIEN-CHING HUNG; Chen Y.-C. |
| 臺大學術典藏 |
2021-12-01T02:30:42Z |
Bacteremia and fungemia in patients with advanced human immunodeficiency virus (HIV) infection in Taiwan
|
CHIEN-CHING HUNG; Hsueh P.-R.; Hsieh S.-M.; Liu C.-J.; Chen M.-Y.; Luh K.-T. |
| 臺大學術典藏 |
2021-12-01T02:30:34Z |
Amebic liver abscess and human immunodeficiency virus infection: A report of three cases
|
Liu C.-J.; CHIEN-CHING HUNG; Chen M.-Y.; Lai Y.-P.; Chen P.-J.; Huang S.-H.; Chen D.-S. |
| 臺大學術典藏 |
2021-12-01T02:29:06Z |
Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection: Real-world effectiveness and safety in Taiwan
|
Liu C.-H.; Liu C.-J.; CHIEN-CHING HUNG; Hsieh S.-M.; Su T.-H.; Sun H.-Y.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-11-18T04:57:53Z |
Enrichment of human CCR6+ regulatory t cells with superior suppressive activity in oral cancer
|
Lee J.-J; Kao K.-C; Chiu Y.-L; Jung C.-J; Liu C.-J; Cheng S.-J; Chang Y.-L; JENG-YUH KO; Chia J.-S. |
| 臺大學術典藏 |
2021-11-15T07:48:14Z |
Enrichment of human CCR6+ regulatory t cells with superior suppressive activity in oral cancer
|
Lee J.-J; Kao K.-C; Chiu Y.-L; Jung C.-J; Liu C.-J; Cheng S.-J; Chang Y.-L; JENG-YUH KO; Chia J.-S. |
